A Prospective, Multi-Center Registry to assess Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization in an Indian Population of Unrestricted Patients - None.
Phase of Trial: Phase IV
Latest Information Update: 29 Aug 2016
At a glance
- Drugs Everolimus (Primary)
- Indications Cardiovascular disorders; Coronary artery disease; Coronary artery restenosis
- Focus Adverse reactions; Therapeutic Use
- 25 Sep 2013 Status changed from recruiting to completed as reported by Clinical Trials Registry - India.
- 08 Aug 2012 New trial record
- 18 Jul 2012 Status changed from not yet recruiting to recruiting as reported by Clinical Trials Registry - India.